INTRODUCTION
E-cadherin is a transmembrane glycoprotein that functions in the formation of adherens junctions in epithelial cells. E-cadherin mediates calcium-dependent, homotypic adhesion between like molecules on adjacent cells. The structure of E-cadherin consists of five extracellular domains, a transmembrane domain, and a cytoplasmic domain [1] . In the cytoplasmic domain, E-cadherin can bind to either b-or g-catenin, which in turn bind to a-catenin and links E-cadherin to the actin cytoskeleton. It has been demonstrated that the b-catenin binding domain of E-cadherin is critical for E-cadherin adhesive function [2, 3] .
Other than mediating inter-cellular adhesion, E-cadherin can also mediate intracellular signaling and has been shown to play a role in cell survival. It has been shown that E-cadherin plays a role in anchorageindependent growth and survival of squamous carcinoma cells and can suppress apoptosis of immortalized granulosa cells [4, 5] . N-cadherin can also mediate cell survival in several cell types [6] [7] [8] [9] . Our laboratory demonstrated E-cadherin-mediated aggregationdependent survival through the retinoblastoma cell cycle control pathway when prostate epithelial cells are challenged with cell death stimuli from PKC activation [10] . Activation of PKC in LNCaP cells resulted in both a viable and apoptotic cell population. Cells which were able to aggregate and become contact-inhibited were found to be viable and contained functional E-cadherin [10] . Examination of the non-aggregated cell population revealed the presence of highly stable 97-and 100-kDa E-cadherin proteolytic cleavage fragments, which lacked the b-catenin binding domain [11, 12] . Recently, we have found that the 100-kDafragment (E-cad 100 ) was generated by calpain protease in response to PKC activation, as well as calcium ionophore treatment [12] . The role of this cleavage fragment in the cell survival of prostate epithelial cells has not been investigated.
E-cadherin proteolysis was first identified by the discovery of a soluble 80-kDa extracellular fragment of E-cadherin that was able to disrupt cell-cell adhesion [13] . This soluble form of E-cadherin is likely generated by stromelysin-1 and matrilysin cleavage [14] . E-cadherin has also been shown to be targeted by caspases during apoptosis [15] . Our laboratory has recently shown that calpain protease mediates the cleavage of E-cadherin to generate a stable 100-kDa fragment (E-cad 100 ), which is slightly larger than the 80-kDa fragment. We postulated that the generation of a b-catenin-binding deficient fragment of E-cadherin may have specific functional consequences in cell survival. However, the function of a defined proteolytic cleavage product of E-cadherin has yet to be uncovered.
Calpain can participate in apoptotic programs in some cell types, although the precise role of calpain in apoptosis remains to be elucidated [16] . Recent studies indicate that there may be a crosstalk between the calpain and caspase proteolytic systems [17] [18] [19] . We have previously shown that calpain can rapidly generate E-cad 100 in response to PKC activation or calcium ionophore, which are known inducers of apoptosis in LNCaP cells [12, 20, 21] . It is postulated therefore, that E-cad 100 may play a role in the apoptotic cascade in these cells by actively disrupting aggregation-dependent survival. We investigated E-cad 100 overexpression in LNCaP prostate epithelial cells and its potential role in cell survival.
MATERIALS AND METHODS

Tissue Culture Cell Lines and Transfections
The LNCaP, MCF-7 and SKBR3 cell lines were grown in 7.5% FBS supplemented with 2 mM L-glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin. LNCaP stable cell lines were supplemented with 600 mg/ml G418 (Bio Whittaker). Cells were incubated at 378C and subcultured weekly. Transfection of LNCaP cells was performed using DMRIE-C reagent according to the manufacturer's protocol (Invitrogen). The population of cells which had the strongest expression of GFP was selected using fluorescence activated cell sorting (FACS) (University of Michigan Flow Cytometry Core). Briefly, the top 10% of cells expressing GFP were collected following transfection and were re-plated in media supplemented with G418 to generate stable cell lines. TPA was used at a final concentration of 10 nM (Alexis Biochemicals).
Inserting Stop Codons
E-cadherin stop mutants were generated by inserting stop codons in the cDNA sequence of a wild-type E-cadherin plasmid [12] . To generate N809Stop, the codon which coded for an asparigine at amino acid 809 was replaced with a stop codon in the cDNA sequence of a wild-type E-cadherin plasmid template [12] . The following primers were used in the Quikchange kit (Stratagene) to generate the N809Stop mutant plasmid, forward: 5 0 CCG ATG AAA TTG GAT AGT TTA TTG ATG 3 0 ; reverse: 5 0 CAT CAA TAA ACT ATC CAA TTT CAT CGG 3 0 . Stop codons were also inserted after codons R784, Y797, and P801. Primers that were used to generate these truncation mutants will be provided upon request.
To generate the E-cad 100 -GFP construct, a Sac II site was inserted after the glycine in the amino acid sequence DEIGN 809 in the cDNA sequence of the same wild-type E-cadherin plasmid template [12] . This was the same location that the stop codon was inserted to generate N809Stop. The primers that were used to insert the SacII site were as follows: forward 5 0 CCG ATG AAA TTG GAC CGC GGA ATT TTA TTG 3 0 ; reverse 5 0 CAA TAA AAT TCC GCG GTC CAA TTT CAT CGG 3 0 . The 5 0 HindIII/SacII 3 0 fragment was then ligated into the pEGFP-N1 vector (Clontech). To create full-length E-cad 120 -GFP, a Sac II site was inserted after the last codon in a wild-type E-cadherin plasmid [12] . This fragment was then ligated into the pEGFP-N1 vector.
Immunoprecipitation
Protein lysates were prepared from cultured cells in the following buffer: 50 mM Tris, pH 7.5, 120 mM NaCl, 0.5% Nonidet p-40, 40 mM phenylmethylsulfonyl fluoride (PMSF), 50 mg/ml leupeptin, 50 mg/ml aprotinin, 200 mM orthovanadate, and 1 mM EGTA. Cells were allowed to lyse 1 hr on ice, centrifuged, supernatants extracted, and quantitated using a Bradford assay. Lysates were separated by 6% NOVEX gels and analyzed using chemiluminescence (Amersham Pharmacia Biotech). For isolation of the cell membrane/ organelle fraction, the ProteoExtract kit was used (Calbiochem).
For immunoprecipitations, cell lysates were prepared and quantitated as described above. The lysates were pre-cleared for 30 min at 48C with protein-A sepharose beads (Zymed Laboratories). All beads were diluted and mixed for 1 hr at room temperature with an equal volume of TBST (50 mM Tris, pH 7.5, 120 mM NaCl, 2% Tween 20) þ 2.5% milk prior to use. Following pre-clearing, lysates were aliquotted into microcentrifuge tubes, where an equal volume of lysate was used for each immunoprecipitation reaction. The volumes of each reaction were equalized to 500 ml with lysis buffer, 5 mg of primary antibody was added, and the reaction was carried out at 48C rotating endover-end. The following day, the beads were added and the reaction was allowed to continue to rotate end-over-end at 48C for 90 min. The beads were then pelleted and washed three times with lysis buffer (þprotease inhibitors). Reducing sample buffer was added to each pellet, boiled for 5 min, centrifuged, and the supernatants loaded onto 6% NOVEX Tris/Gly (Invitrogen) gels for Western analysis.
The antibodies used in immunoprecipitation and Western blot analysis were E-cadherin (HECD-1, Zymed), b-catenin (C2206, Sigma), GFP (MAB3580, Chemicon), and hsp-70 (MAB3516, Chemicon).
Immunofluorescence Staining
Chamber slides were coated with 5 mg/ml Fibronectin (F-1141, Sigma) in PBS overnight prior to cell plating. 3.0 Â 10 5 LNCaP stable cell lines were plated and grown for 2 days. Cells were fixed with 2% formaldehyde followed by 100% ethanol, each for 5 min on ice. Cells were washed in PBS and blocked with TBST þ 10% non-fat milk þ 1.5% heat-inactivated FBS for 30 min at room temperature. Anti-b-catenin (Sigma) or anti-E-cadherin antibody was added (SC-1499, Santa Cruz) for 50 min at room temperature. After washing in blocking solution, cells were incubated with rhodamine-conjugated anti-goat or anti-rat secondary antibody for 1 hr at room temperature (Santa Cruz). Cells were washed and visualized with an Olympus inverted fluorescent microscope. For immunostaining of transiently transfected cells, 2.0 Â 10 5 MCF-7 cells were plated and grown for 24 hr. They were then transfected with E-cad 100 -GFP using the FuGene 6 reagent for 48 additional hr. Cells were then fixed and stained with anti-E-cadherin antibody as described above.
Cell Viability Assay 1.5 Â 10 5 cells were plated in 6-well dishes. Cells were treated with TPA when they reached 50% confluence. At time 0 and at 24 hr post-treatment, the attached cells which stained with trypan blue were counted (Gibco).
Statistical analyses were performed using a Student's paired t-test with a two-tailed distribution. P < 0.05 was considered statistically significant.
Densitometry
Densitometric analysis was performed using the Scion Image software. The ratio of band intensity between endogenous E-cadherin and Hsp-70 in the LNCaP E-cad 100 -GFP cell line was compared to the ratio in the LNCaP vector cell line, which was normalized to one.
RESULTS
TPATreatment Induces LNCaP Cell-Death and Generation of E-cad 100
Our laboratory has previously identified a 100-kDa E-cadherin fragment (E-cad 100 ) that was generated by calpain in prostate and mammary epithelial cells in response to PKC activation or calcium influx [12] . PKC activation by treatment of cells with 12-Otetradecanoylphorbol-13-acetate (TPA) resulted in cellular aggregation of which the aggregated cells remained viable (Fig. 1A) . However, a substantial proportion of cells were dissociated and rapidly underwent apoptosis (Fig. 1A) [10, 20] . The viability of the TPA-treated cell population was significantly less (70%) than untreated cells (88%) (Fig. 1A) . We have previously shown that aggregation-dependent survival of LNCaP cells required E-cadherin [10] . We hypothesized that PKC-induced apoptosis was associated with the disruption of the E-cadherin adhesion complex. Treatment of LNCaP cells with TPA resulted in the generation of E-cad 100 , which was previously shown to be mediated by calpain (Fig. 1B) [12] . Previously, we have shown that disruption of E-cadherinmediated adhesion using an E-cadherin blocking antibody potentiated TPA-induced apoptosis of LNCaP cells [10] . Furthermore, it has been shown that the 80-kDa E-cadherin fragment also disrupts cell adhesion [13] . Based on these studies and our results, we hypothesized that E-cad 100 might be affecting cell survival of LNCaP cells.
Localization of E-cad 100 Cleavage Site
To investigate the role of E-cad 100 , we mapped the calpain cleavage site in order to engineer an E-cad 100 construct. An E-cadherin antibody that maps to the extracellular domain of E-cadherin detected both fulllength E-cadherin and E-cad 100 ( Fig. 2A) . In contrast, a C-terminal antibody to E-cadherin detected full-length E-cadherin but failed to detect E-cad 100 , suggesting that the calpain cleavage site resided in the cytoplasmic domain of E-cadherin ( Fig. 2A) . In order to ascertain the E-cad 100 cleavage site more precisely, E-cadherin mutants were created in which stop codons were inserted in wild-type E-cadherin cDNA, resulting in a truncated E-cadherin protein at potential calpain cleavage sites (Fig. 2B) . The calpain consensus site has been shown to contain a valine, leucine, or isoleucine at the P2 position, and a tyrosine, glycine, or arginine at the P1 position, though the amino acids at the P1 position can be varied [16] . Stop codons were inserted in the cDNA to replace the codon for the amino acid indicated (Fig. 2B) . These E-cadherin truncation mutants were then transiently expressed in E-cad À/À SKBR3 cells and immunoblotted with an antibody which recognizes the extracellular domain of Ecadherin (Fig. 2C) . Alignment of the expressed Ecadherin truncation mutants with endogenous E-cad 100 demonstrated that the truncation following the asparigine at amino acid 809 had an identical electrophoretic mobility to endogenous E-cad 100 . This particular mutant also contained a consensus calpain cleavage site consisting of an isoleucine at the P2 position, and a glycine at the P1 position [16] . This mutant was therefore chosen to represent exogenous E-cad 100 in future experiments.
Expression of E-cadherin/GFP Constructs in LNCaP Cells
The E-cad 100 fragment was cloned into a GFP vector, and stably expressed in LNCaP cells. LNCaP stable cell lines expressing a full-length, wild-type E-cadherin-GFP construct, as well as the empty GFP vector were also created. High expression of these proteins in the cell lines was achieved by subjecting the transfected pools to FACS, in which the top 10% of fluorescing cells were collected and re-plated in selection media (data not shown). The cell lines were visualized using fluorescence microscopy to determine the level of expression of the expressed proteins. The LNCaP vector cell line displayed whole cell staining of the GFP protein (Fig. 3A) . As expected, the LNCaP Ecad
120
-GFP cell line demonstrated strong E-cadherin staining at the cell membrane (Fig. 3A) . In contrast, . A: A schematic of full-length E-cadherin and E-cad 100 is shown. An antibody to the extracellular domain (antibody A) detected E-cad 100 in contrast to the C-terminal antibody (antibody B), which did not detect E-cad 100 . B: Codons which encoded for amino acids that followed potential calpain cleavage sites were replaced with stop codons in the cDNA of a wild-type E-cadherin plasmid. C: Stop mutants were transiently transfected in SKBR3 cells and whole cell extracts were resolved by SDS^PAGE followed by immunoblotting with an E-cadherin antibody.The control lane represents cell lysate fromTPA-treated LNCaPcells.
E-cad
100
-GFP cell line demonstrated punctuate expression, which seemed to be localized to both the membrane and cytoplasm (Fig. 3A) . Additionally, these cells displayed a more flattened phenotype than the control cell lines.
Western blot analysis demonstrated that the E-cad 120 -GFP and the E-cad 100 -GFP fusion proteins, which have molecular weights of 150-and 130-kDa, respectively, were stably expressed in the transfected cell lines (Fig. 3B) . These proteins were detected with both anti-E-cadherin and anti-GFP antibodies (Fig. 3B) . To test whether the E-cad 100 -GFP protein associated with bcatenin, a co-immunoprecipitation assay was performed (Fig. 4A) . Co-immunoprecipitation with a GFP-antibody demonstrated that E-cad 120 -GFP bound strongly to b-catenin, while E-cad 100 -GFP did not exhibit binding, confirming that this calpain-generated fragment has lost the b-catenin binding domain (Fig. 4A) . The reciprocal experiment demonstrated that E-cad 120 -GFP, but not E-cad 100 -GFP could be coimmunoprecipitated with a b-catenin antibody (Fig. 4B) . These results demonstrated that E-cad 100 -GFP did not possess the b-catenin binding domain.
E-cad 100 -GFP Does Not Localize With b-Catenin
We next investigated whether the GFP-tagged Ecadherin proteins co-localized with endogenous b-catenin. The LNCaP E-cad 120 -GFP and LNCaP E-cad 100 -GFP cell lines were stained for b-catenin and examined using immunofluorescence microscopy. E-cad 120 -GFP was localized primarily at the membrane, and exhibited strong junctional staining (Fig. 5A) . b-catenin was also localized primarily at the membrane and an overlay of the images demonstrated strong co-localization of E-cad 120 -GFP and endogenous b-catenin ( 
and E). In contrast, E-cad
100 -GFP displayed a punctuate expression pattern (Fig. 5B) . Expression of b-catenin remained localized to the membrane, presumably through association with endogenous E-cadherin (Fig. 5D) . However, the merged image demonstrated that E-cad 100 -GFP does not co-localize with endogenous b-catenin, supporting the results obtained from the co-immunoprecipitation experiments (Fig. 5F ).
E-cad 100 Downregulates Endogenous E-Cadherin Expression
Previous studies have shown that overexpression of truncated cadherin constructs can affect the expression of endogenous cadherin protein [22] [23] [24] . We hypothesized that E-cad 100 may function to alter the expression of endogenous E-cadherin in LNCaP cells. We utilized a C-terminal-specific E-cadherin antibody to distinguish between endogenous E-cadherin and E-cad 100 -GFP in immunofluorescence experiments.
In the LNCaP E-cad 100 cell line, or in MCF-7 cells in which E-cad 100 was transiently expressed, cells which were positive for E-cad 100 -GFP expression were found to have marked downregulation of endogenous membrane E-cadherin expression (Fig. 6A) . Similarly, cells which lacked GFP expression had retained endogenous E-cadherin expression (Fig. 6A) . The percentage of GFP positive cells that contained downregulated endogenous E-cadherin was over 80% in both the LNCaP E-cad 100 cell line and in MCF-7 cells in which E-cad 100 -GFP was transiently expressed (Fig. 6A ). To biochemically test whether endogenous membrane E-cadherin was being downregulated in E-cad 100 -GFP overexpressing cells, cell membrane extracts of LNCaP vector and LNCaP E-cad 100 -GFP cells were prepared and analyzed by Western blot for E-cadherin. Downregulation of endogenous E-cadherin was observed in LNCaP E-cad 100 -GFP cells compared to vector control (Fig. 6B) . Densitometric analysis demonstrated a 40% reduction of endogenous E-cadherin expression in E-cad 100 -overexpressing cells compared to vector control (Fig. 6C ). These data demonstrate that E-cad 100 -GFP overexpression downregulates endogenous membrane E-cadherin expression.
Overexpression of E-cad 100 Potentiates PKC-Induced Apoptosis
We have previously elucidated a role for E-cadherin in aggregation-dependent survival of LNCaP cells, in which PKC-induced aggregation of LNCaP cells resulted in the E-cadherin-dependent survival of aggregated cells, and death of cells unable to aggregate [10] . We hypothesized, therefore, that downregulation of functional endogenous E-cadherin through overexpression of E-cad 100 could potentially lead to an impaired ability of cells to aggregate and results in an inhibition of cell survival. To test this hypothesis, LNCaP E-cad 100 -GFP, LNCaP E-cad 120 -GFP, and LNCaP vector control cells were treated with TPA for 24 hr and the viability of the aggregated cell population was measured in a trypan blue exclusion assay. TPA treatment resulted in the death of 24% in the control cells and 27% in E-cad 120 -GFP-overexpressing cells (Fig. 7) . In contrast, TPA treatment resulted in the death of 38% of cells overexpressing E-cad 100 -GFP, which was statistically significant. These results demonstrate that E-cad 100 overexpression in the aggregated LNCaP cell population potentiated cell death following PKC activation and suggested that E-cad 100 can functionally inhibit cell survival.
DISCUSSION
We have demonstrated a role for a truncated E-cadherin species, which represents a physiologic, calpain-generated fragment of E-cadherin, in inhibiting aggregation-dependent survival in prostate epithelial cells. Co-localization and co-immunoprecipitation experiments confirmed that E-cad 100 -GFP did not associate with b-catenin. Fluorescence microscopy analysis Fig. 6 . E-cad 100 overexpressiondownregulates endogenous E-cadherin.A:LNCaP E-cad 100 -GFPcells or MCF-7 cells transiently transfected with E-cad 100 -GFP were stained with a C-terminal E-cadherin antibody (bottom panels) and visualized for GFP (top panels). Arrows depict cells which express E-cad 100 -GFP and contain downregulated endogenous E-cadherin. Magnification is at 40Â. B: The membrane/ organelle fractions of untreated LNCaP vector and LNCap E-cad 100 -GFP cells were isolated, resolved by SDS^PAGE and immunoblotted for E-cadherin.Theblotwasre-probedfor hsp-70 as a loadingcontrol.C:TheWesternblotin (B) was subjected to densitometric analysis.Theratio ofendogenousE-cadherinto thehsp-70loadingcontrolwascomparedbetweenLNCaPE-cad100 -GFPcellsandLNCaP vectorcells.Theresultis representative of two experiments. [Color figure canbeviewedin the onlineissue, whichis available at www.interscience.wiley. com.] revealed that E-cad 100 -GFP expression downregulated membrane E-cadherin expression, and functionally potentiated cell death. These results imply a role of E-cad 100 in the regulation of LNCaP cell survival. Cell-matrix and cell-cell contacts have been shown to propagate cellular survival signals [4, 10, 25, 26] . The disruption of these contacts by intracellular proteases has been demonstrated. Caspases have been shown to cleave proteins in the focal adhesion complex, such as focal adhesion kinase and paxillin [27, 28] . In addition, caspases have been shown to target E-cadherin and b-catenin in some apoptotic programs [15, 29] . Despite an established role for caspases in apoptosis, there is evidence that calpain can also play a role in some apoptotic processes [30] [31] [32] . Calpain has also been shown to proteolytically cleave proteins in the focal adhesion complex, such as integrins, as well as cytoskeletal substrates during apoptosis [33] [34] [35] . Our data suggests that the cytoplasmic domain of E-cadherin, the main component of the adherens junction, is cleaved during PKC-induced apoptosis of LNCaP cells. We hypothesized that this cleavage, which removes the b-catenin binding domain, adversely affects cell survival.
To investigate the role of E-cad 100 in cell survival, an E-cad 100 -GFP construct was engineered. Fluorescence microcopy revealed that the expression pattern of E-cad 100 -GFP was punctate in nature, compared to membranous staining for E-cad 120 -GFP. These results are similar to findings from a previous study, which demonstrated punctuate expression of overexpressed E-cadherin mutants which contained truncations in the cytoplasmic domain [2] . The cytoplasmic localization of these mutants likely stems from the lack of association of these cadherins to the actin cytoskeleton. Subcellular fractionation of TPA-treated LNCaP lysates and cells expressing E-cad 100 -GFP demonstrated that both endogenous and exogenous E-cad 100 resided exclusively in membrane biochemical compartments, which consist of plasma and organelle membranes (data not shown). We speculate then, that endogenous E-cad 100 may be internalized following cleavage and be localized similarly to exogenous E-cad 100 . Alternatively, endogenous E-cad 100 may retain association with the plasma membrane. The lack of an antibody that can specifically detect endogenous E-cad 100 and not full-length E-cadherin prevents determination of its precise localization via immunofluorescence microscopy.
We have shown that overexpression of E-cad 100
downregulates endogenous E-cadherin at the membrane and that this inhibits cell survival. One of the ways in which E-cadherin may promote cell survival is through association with growth factor signaling pathways. It has been shown that the engagement of E-cadherin at cell-cell contacts can activate both PI3 and MAP kinase pathways [36, 37] . b-catenin links E-cadherin to the epidermal growth factor receptor, and has been shown to associate with the p85 subunit of PI3 kinase [38, 39] . The removal of the b-catenin binding domain by calpain may therefore remove the association of E-cadherin with growth factor receptors and this might inhibit the survival of cells when challenged with death stimuli. Prior studies have shown that transfection of truncated cadherin molecules can affect the expression of endogenous cadherin protein [22, 23] . We hypothesize that a reduction in membranous fulllength E-cadherin resulting from E-cad 100 overexpression might result in a hindrance of cells to mediate cell survival signals upon receipt of cell death stimuli. Thus, we propose that cleavage of E-cadherin might inhibit cell survival in two ways: through the removal of the b-catenin binding domain of intact E-cadherin at the plasma membrane, and the separate effect of this fragment on downregulation of endogenous membrane E-cadherin.
The finding that E-cad 100 inhibits membrane endogenous E-cadherin expression raised the question of the mechanism of how this occurs. One possibility is that E-cad 100 binds to endogenous E-cadherin and sequesters it in the cytoplasm, preventing it from reaching the cell surface. It has been shown that E-cadherin can form cis-dimers on the membrane of cells [40] . However, no evidence has been reported of E-cadherin forming homodimers in the cytoplasm, and this is unlikely since E-cad 100 and endogenous E-cadherin did not co-localize in this study. Another Fig. 7 . E-cad 100 overexpression potentiates PKC-induced cell death. LNCaP vector, LNCaP E-cad 120 -GFP, and LNCaP E-cad 100 -GFP cells were treated withTPA for 24 hr. The percentage of dead cells before and after treatment was determined.The experiment was performed in triplicate. The percentage of dead cells in the LNCaP E-cad 100 -GFP cell line was significantly higher than the TPA-treated control cell lines (P < 0.05).
possibility is that the retention of E-cad 100 in cytoplasmic compartments impairs the cell surface transport of both itself and endogenous E-cadherin. The exact mechanism of how this regulation occurs remains to be elucidated.
Many previous studies have examined the biological role of E-cadherin mutants which lack cytoplasmic domains and have demonstrated that this domain is required for normal cell adhesion [2, 3, 41] . Previous studies from our lab demonstrated a novel, calpain-dependent physiological pathway in which the b-catenin binding domain is removed [12] . We propose that the removal of this domain leads to disruption of cellular adhesion and can inhibit cellular survival following apoptotic stimuli.
